Drupal.behaviors.print = function(context) {window.print();window.close();}>
Genomic Health Hopes Decision-Making Study Results Will Drive Colon Cancer Dx Adoption, Payment
January 25, 2012
Genomic Health Hopes Decision-Making Study Results Will Drive Colon Cancer Dx Adoption, Payment
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Genomic Health Sets Sights on Expanding Oncotype DX for Later-Stage Colorectal Cancer, Other Areas
January 27, 2010 / Pharmacogenomics Reporter
Prospective Comparison of Oncotype DX and Central Pathology Assessment Shows HER2 Discordance
July 3, 2012 / Pharmacogenomics Reporter
Absent 'Gold Standard' for HER2 Testing, Researchers Question Role of Oncotype DX Beyond IHC/FISH
December 21, 2011 / Pharmacogenomics Reporter
Oncotype DX Study Raises Questions About RT-PCR Testing for HER2 Expression
December 1, 2011 / PCR Insider
AMA Proposes New Coding Criteria for Multi-Analyte Algorithm-Based Tests
November 9, 2011 / Pharmacogenomics Reporter